The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Mitochondrial disorders are caused by gene mutations in mitochondrial or nuclear DNA and affect energy-dependent organs such as the brain. Patients with psychiatric illness, particularly those with medical comorbidities, may have primary mitochondrial disorders. To date, this issue has received little attention in the literature, and mitochondrial disorders are likely underdiagnosed in psychiatric patients. DATA SOURCES: This article describes a patient who presented with borderline personality disorder and treatment-resistant depression and was ultimately diagnosed with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) 3271. We also searched the literature for all case reports of patients with mitochondrial disorders who initially present with prominent psychiatric symptoms by using MEDLINE (from 1948-February 2011), Embase (from 1980-February 2011), PsycINFO (from 1806-February 2011), and the search terms mitochondrial disorder, mitochondria, psychiatry, mental disorders, major depression, anxiety, schizophrenia, and psychosis. STUDY SELECTION: Fifty cases of mitochondrial disorders with prominent psychiatric symptomatology were identified. DATA EXTRACTION: Information about the psychiatric presentation of the cases was extracted. This information was combined with our case, the most common psychiatric manifestations of mitochondrial disorders were identified, and the important diagnostic and treatment implications for patients with psychiatric illness were reviewed. RESULTS: The most common psychiatric presentations in the cases of mitochondrial disorders included mood disorder, cognitive deterioration, psychosis, and anxiety. The most common diagnosis (52% of cases) was a MELAS mutation. Other genetic mitochondrial diagnoses included polymerase gamma mutations, Kearns-Sayre syndrome, mitochondrial DNA deletions, point mutations, twinkle mutations, and novel mutations. CONCLUSIONS: Patients with mitochondrial disorders can present with primary psychiatric symptomatology, including mood disorder, cognitive impairment, psychosis, and anxiety. Psychiatrists need to be aware of the clinical features that are indicative of a mitochondrial disorder, investigate patients with suggestive presentations, and be knowledgeable about the treatment implications of the diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have shown that psychiatric illnesses are common in patients with mitochondrial diseases. 3 , 4 , 5 , 6”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [3]
In the citing paper
“and these include SSRIs, 12 , 14 , 15 SNRIs, 3 MAOIs, 4 antipsychotics, 16 , 17 , 18 and sodium‐valproate 19 , 20 , 21 , 22”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [3]
Citations
Cites
Still being checked.
Cited by
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options
El-Hattab, A. W., Adesina, A. M., Jones, J., & Scaglia, F. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.06.004 · Cited by 610
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434
Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
Rajasekaran, A., Venkatasubramanian, G., Berk, M., & Debnath, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.005 · Cited by 279
Mitochondrial iron–sulfur protein biogenesis and human disease
Stehling, O., Wilbrecht, C., & Lill, R. (2014) · Biochimie · doi:10.1016/j.biochi.2014.01.010 · Cited by 272
High anxiety trait: A vulnerable phenotype for stress-induced depression
Weger, M., & Sandi, C. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.012 · Cited by 270
OXPHOS mutations and neurodegeneration
Koopman, W. J. H., Distelmaier, F., Smeitink, J. A., & Willems, P. H. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.300 · Cited by 254
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 187
Moylan, S., Jacka, F. N., Pasco, J. A., & Berk, M. (2013) · Brain and Behavior · doi:10.1002/brb3.137 · Cited by 186
“First, patients exhibiting mitochondrial disorders commonly demonstrate psychiatric symptoms including increased anxiety (Miyaoka et al. 1997; Anglin et al. 2012).”
BackgroundVitamin D and Depression: Cellular and Regulatory Mechanisms
Berridge, M. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013227 · Cited by 182
Anxiety and Brain Mitochondria: A Bidirectional Crosstalk
Filiou, M. D., & Sandi, C. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.07.002 · Cited by 161
A mitochondrial bioenergetic basis of depression
Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 164
Mitochondria and the economy of stress (mal)adaptation
Morava, É., & Kozicz, T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.005 · Cited by 128
Frye, R. E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.134 · Cited by 117
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease
Tobore, T. O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03863-x · Cited by 121
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Culmsee, C., Michels, S., Scheu, S., Arolt, V., Dannlowski, U., & Alferink, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00739 · Cited by 110
Xu, H., & Yang, F. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02233-0 · Cited by 135
Jiang, M., Wang, L., & Sheng, H. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14576 · Cited by 111
Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system
Weckmann, K., Deery, M. J., Howard, J. A., Feret, R., Asara, J. M., Dethloff, F., Filiou, M. D., Iannace, J., Labermaier, C., Maccarrone, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16183-x · Cited by 87
An overview of medical risk factors for childhood psychosis: Implications for research and treatment
Giannitelli, M., Consoli, A., Raffin, M., Jardri, R., Levinson, D. F., Cohen, D., & Laurent‐Levinson, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.011 · Cited by 94
Zheng, W., Zhang, Q. ‐., Cai, D. ‐., Yang, X. ‐., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y. ‐., & Xiang, Y. ‐. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12862 · Cited by 81
The Psychiatric Presentation of Mitochondrial Disorders in Adults
Anglin, R. E., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11110345 · Cited by 77
Self-citationFeier, G., Valvassori, S. S., Varela, R. B., Resende, W. R., Bavaresco, D. V., Morais, M. O. D. S., Scaini, G., Andersen, M. L., STRECK, E. L., & Quevedo, J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.010 · Cited by 76
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 75
The mitochondrial genome and psychiatric illness
Anglin, R. E. S., Mazurek, M. F., Tarnopolsky, M. A., & Rosebush, P. I. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32086 · Cited by 68
Self-citationPan, L. A., Martin, P., Zimmer, T., Segreti, A. M., Kassiff, S., McKain, B. W., Baca, C. A., Rengasamy, M., Hyland, K., Walano, N., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15111500 · Cited by 68
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
Martin, D. A., Marona-Lewicka, D., Nichols, D. E., & Nichols, C. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.013 · Cited by 67
Смагин, Д. А., Kovalenko, I. L., Galyamina, A. G., Брагин, А. О., Orlov, Y. L., & Kudryavtseva, N. N. (2015) · Neural Plasticity · doi:10.1155/2016/3289187 · Cited by 77
Woo, H.-I., Chun, M., Yang, J., Lim, S., Kim, M., Kim, S., Myung, W., Kim, D., & Lee, S. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12372 · Cited by 67
Gokhale, A., Hartwig, C. L., Freeman, A. A. H., Bassell‐Hawkins, J., Zlatic, S. A., Savas, C. S., Vadlamudi, T., Abudulai, F., Pham, T. T., Crocker, A. J., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1983-18.2019 · Cited by 78
ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications
Homaei, S. C., Halleland, H. B., Kleppe, R., Betari, N., Reif, A., & Haavik, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.012 · Cited by 64
Mitochondrial Mutations in Subjects with Psychiatric Disorders
Sequeira, A., Rollins, B. L., Magnan, C., van Oven, M., Baldi, P., Myers, R., Barchas, J. D., Schatzberg, A. F., Watson, S. J., Akil, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127280 · Cited by 59
Torrell, H., Montaña, E., Abasolo, N., Roig, B., Gaviria, A. M., Vilella, E., & Martorell, L. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32134 · Cited by 52
Fan, H., Lee, H.-F., Yue, C.-T., & Chi, C. (2021) · Life · doi:10.3390/life11111111 · Cited by 63
NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia
Bergman, O., Karry, R., Milhem, J., & Ben‐Shachar, D. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0309-9 · Cited by 52
Bipolar Disorder as a Mitochondrial Disease
Andreazza, A. C., Duong, A., & Young, L. T. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.09.018 · Cited by 49
Efavirenz Induces Neuronal Autophagy and Mitochondrial Alterations
Purnell, P. R., & Fox, H. S. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217869 · Cited by 55
Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment
Kumar, P., Efstathopoulos, P., Millischer, V., Olsson, E., Wei, Y. B., Brüstle, O., Schalling, M., Villaescusa, J. C., Ösby, U., & Lavebratt, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-31122-0 · Cited by 59
Rappeneau, V., Wilmes, L., & Touma, C. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103555 · Cited by 52
Zacharias, H. U., Hertel, J., Johar, H., Pietzner, M., Lukaschek, K., Atasoy, S., Kunze, S., Völzke, H., Nauck, M. A., Friedrich, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01176-0 · Cited by 49
Resende, R., Fernandes, T., Pereira, A. C., Pascale, J. D., Marques, A. P., Oliveira, P., Morais, S., Santos, V. L. C. D. G., Madeira, N. G. G. F., Pereira, C., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165752 · Cited by 42
Na, J., & Lee, Y. (2024) · Biomolecules · doi:10.3390/biom14121524 · Cited by 38
Aboul‐Fotouh, S. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283654029 · Cited by 38
Accelerated aging in major depression: the role of nitro-oxidative stress
Luca, M., Luca, A., & Calandra, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/230797 · Cited by 37
“In fact, oxidative mtDNA damage has been demonstrated in this psychiatric disorder, which can even represent a manifestation of certain mitochondrial diseases [45–47].”
BackgroundHolper, L., Lan, M. J., Brown, P. J., Sublette, M. E., Burke, A. K., & Mann, J. J. (2019) · Depression and Anxiety · doi:10.1002/da.22913 · Cited by 38
Mitochondrial dynamics and psychiatric disorders: The missing link
Papageorgiou, M. P., & Filiou, M. D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105837 · Cited by 43
Zhao, Y., Chen, Y., Guo, C., Li, P., Cheng, Z., Zheng, L., Sha, B., Xu, H., Su, X., & Wang, Y. (2024) · Theranostics · doi:10.7150/thno.92676 · Cited by 40
Payares, D. V. P., Spooner, L., Vosters, J. A., Dominguez, S., Patrick, L., Harris, A., & Kanungo, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1389093 · Cited by 40
Effect of neuropsychiatric medications on mitochondrial function: For better or for worse
Emmerzaal, T. L., Nijkamp, G., Veldić, M., Rahman, S., Andreazza, A. C., Morava, É., Rodenburg, R. J., & Kozicz, T. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.001 · Cited by 40
The somatic common deletion in mitochondrial DNA is decreased in schizophrenia
Mamdani, F., Rollins, B. L., Morgan, L., Sequeira, A., & Vawter, M. P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.08.026 · Cited by 38
Stauch, K. L., Emanuel, K. M., Lamberty, B. G., Morsey, B., & Fox, H. S. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0573-5 · Cited by 36
Clinical syndromes associated with mtDNA mutations: where we stand after 30 years
Carelli, V., & Morgia, C. L. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170097 · Cited by 41
Triebelhorn, J., Cardon, I., Kuffner, K., Bader, S. M., Jahner, T., Meindl, K., Rothhammer-Hampl, T., Riemenschneider, M. J., Drexler, K., Berneburg, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01660-1 · Cited by 40
Eszlári, N., Kovács, D., Petschner, P., Pap, D., Gonda, X., Elliott, R., Anderson, I. M., Deakin, J. F. W., Bagdy, G., & Juhász, G. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.19 · Cited by 31
Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32
Leukocyte mitochondrial DNA copy number in schizophrenia
Shivakumar, V., Rajasekaran, A., Subbanna, M., Kalmady, S. V., Venugopal, D., Agrawal, R., Amaresha, A. C., Agarwal, S. M., Joseph, B., Narayanaswamy, J. C., et al. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102193 · Cited by 29
Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia
Maguire, Á., Hargreaves, A., & Gill, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1556481 · Cited by 31
Targeting mitophagy for depression amelioration: a novel therapeutic strategy
Xu, W., Gao, W.-P., Guo, Y., Feng, X., Di, L., Fang, S., Fan, L., He, Y., Zhou, Y., Xie, X., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1235241 · Cited by 31
Ghanizadeh, A. J., & Berk, M. (2013) · Medical Gas Research · doi:10.1186/2045-9912-3-11 · Cited by 30
Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression
Cardon, I., Grobecker, S., Jenne, F., Jahner, T., Rupprecht, R., Milenkovic, V. M., & Wetzel, C. H. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02538-0 · Cited by 35
TOMM40 rs2075650 May Represent a New Candidate Gene for Vulnerability to Major Depressive Disorder
McFarquhar, M., Elliott, R., McKie, S., Thomas, E., Downey, D., Mekli, K., Toth, Z. G., Anderson, I. M., Deakin, J. F. W., & Juhász, G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.22 · Cited by 31
Pediatric single large-scale mtDNA deletion syndromes: The power of patient reported outcomes
Reynolds, E., Byrne, M., Ganetzky, R. D., & Parikh, S. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.11.004 · Cited by 25
Anglin, R., Rosebush, P. I., Noseworthy, M. D., Tarnopolsky, M. A., & Mazurek, M. F. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.107 · Cited by 27
Self-citationCongenital and Acquired Disorders Presenting as Psychosis in Children and Young Adults
Benjamin, S., Lauterbach, M. D., & Stanislawski-Zygaj, A. L. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.04.004 · Cited by 27
Neuropsychiatric Features in Primary Mitochondrial Disease
Marin, S. E., & Saneto, R. P. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.08.011 · Cited by 27
A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation
Ryu, E., Nassan, M. M., Jenkins, G. D., Armasu, S. M., Andreazza, A. C., McElroy, S. L., Vawter, M. P., Frye, M. A., & Biernacka, J. M. (2017) · Complex Psychiatry · doi:10.1159/000464444 · Cited by 25
Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
Finsterer, J., & Zarrouk‐Mahjoub, S. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s149067 · Cited by 22
The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
Frison, M., Faccenda, D., Abeti, R., Rigon, M., Strobbe, D., England-Rendon, B. S., Cash, D., Barnes, K., Sadeghian, M., Sajic, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01050-z · Cited by 27
Смагин, Д. А., Kovalenko, I. L., Galyamina, A. G., Orlov, Y. L., Babenko, V. N., & Kudryavtseva, N. N. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0327-z · Cited by 20
Frye, M. A., Ryu, E., Nassan, M. M., Jenkins, G. D., Andreazza, A. C., Evans, J. M., McElroy, S. L., Oglesbee, D., Highsmith, W. E., & Biernacka, J. M. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.027 · Cited by 22
Cognitive functioning and mental health in mitochondrial disease: A systematic scoping review
Klein, I., van de Loo, K. F. E., Smeitink, J. A. M., Janssen, M. C. H., Kessels, R. P. C., van Karnebeek, C., van der Veer, E., Custers, J. A. E., & Verhaak, C. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.004 · Cited by 23
Mental illness in patients with inherited mitochondrial disorders
Rosebush, P. I., Anglin, R., Rasmussen, S. A., & Mazurek, M. F. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.010 · Cited by 21
Self-citationRiquin, É., Duverger, P., Cariou, C., Barth, M., Prouteau, C., Bogaert, P. V., Bonneau, D., & Roy, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00747 · Cited by 19
Mitochondrial DNA as a marker for treatment-response in post-traumatic stress disorder
Hummel, E. M., Piovesan, K., Berg, F., Herpertz, S., Kessler, H., Kumsta, R., & Moser, D. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105993 · Cited by 22
Psychotropic medications and mitochondrial toxicity
Anglin, R., Rosebush, P., & Mazurek, M. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229-c1 · Cited by 17
Self-citationPan, L. A., Segreti, A. M., Wrobleski, J., Shaw, A., Hyland, Κ., Hughes, M. A., Finegold, D. N., Naviaux, R. K., Brent, D. A., Vockley, J., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722003233 · Cited by 23
Nishioka, M., Takayama, J., Sakai, N., Kazuno, A., Ishiwata, M., Ueda, J., Hayama, T., Fujii, K., Someya, T., Kuriyama, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02096-x · Cited by 22
Zottola, A. C. P., Martín-Jiménez, R., Lavanco, G., Hamel-Côté, G., Ramon‐Duaso, C., Rodrigues, R. S., Mariani, Y., Khan, M., Drago, F., Jean, S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02032-y · Cited by 17
The clinical spectrum of MELAS and associated disorders across ages: a retrospective cohort study
Cox, B. C., Pearson, J. Y., Mandrekar, J. N., & Gavrilova, R. H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1298569 · Cited by 14
Tran, H., Shin, E., Saito, K., Tran, T.-V., Phan, D., Sharma, N., Kim, D. W., Choi, S. Y., Jeong, J. H., Jang, C., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110986 · Cited by 15
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)
Goldstein, A. C., & Servidei, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-05517-2_5 · Cited by 15
Brusa, C., Gadaleta, G., D’Alessandro, R., Urbano, G., Vacchetti, M., Davico, C., Vitiello, B., Ricci, F., & Mongini, T. (2022) · Brain Sciences · doi:10.3390/brainsci12020176 · Cited by 14
Psychiatric disturbances in five patients with MELAS syndrome
Magner, M., Honzik, T., Tesarova, M., Dvorakova, V., Hansikova, H., Raboch, J., & Zeman, J. (2014) · Psychiatria Polska · doi:10.12740/pp/24062 · Cited by 11
Wang, K., He, L., Liu, X., & Wu, M. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142651 · Cited by 13
Towards Central Nervous System Involvement in Adults with Hereditary Myopathies
Reimann, J., & Kornblum, C. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200507 · Cited by 13
Ge, Y.-X., Shang, B., Chen, W., Lü, Y., & Wang, J. (2016) · eNeurologicalSci · doi:10.1016/j.ensci.2016.11.005 · Cited by 11
The m.3890G>A/MT-ND1 mtDNA rare pathogenic variant: Expanding clinical and MRI phenotypes
Vacchiano, V., Caporali, L., Morgia, C. L., Carbonelli, M., Amore, G., Bartolomei, I., Cascavilla, M. L., Barboni, P., Lamperti, C., Catania, A., et al. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.007 · Cited by 10
Fissler, P., Vandersmissen, A., Filippi, M., Mavioğlu, R. N., Scholkmann, F., Karabatsiakis, A., & Krähenmann, R. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231164707 · Cited by 11
Cerebral Manifestations of Mitochondrial Disorders
Finsterer, J., & de Carvalho, E. H. T. (2017) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2017.211 · Cited by 9
Cozart, B., Vera, J. D., Denham, J. D., & Whiting, W. L. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000277 · Cited by 9
Anglin, R., Rosebush, P. I., Noseworthy, M. D., Tarnopolsky, M. A., Weber, A. M., Soreni, N., & Mazurek, M. F. (2013) · CMAJ Open · doi:10.9778/cmajo.20120020 · Cited by 8
Self-citationOn elucidation of the role of mitochondria dysfunction and oxidative stress in multiple sclerosis
Tobore, T. O. (2019) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12335 · Cited by 12
Venkatesan, S., Comi, C., Marchi, F. D., Esposito, T., Gramaglia, C. M., Smirne, C., Pour, M. M. O., Pirisi, M., Vaschetto, R., Zeppegno, P., et al. (2026) · Biomolecules · doi:10.3390/biom16010117 · Cited by 10
Kiely, C., Douglas, K. A. A., Douglas, V. P., Miller, J. B., & Lizano, P. L. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115629 · Cited by 9
Rapinesi, C., Janiri, D., Kotzalidis, G. D., Serata, D., CASALE, A. D., Scatena, P., Dacquino, C., Gentile, G., Manfredi, G., Danese, E., et al. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.002 · Cited by 7
Reuß, B., Schroten, H., Ishikawa, H., & Asif, A. R. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0585-7 · Cited by 7
Y Chromosome, Mitochondrial DNA and Childhood Behavioural Traits
Howe, L. J., Erzurumluoglu, A. M., Smith, G. D., Rodríguez, S., & Stergiakouli, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-10871-4 · Cited by 8
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)
Marin, S. E., & Haas, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800877-5.00002-4 · Cited by 7
Boterberg, S., Vantroys, E., Paepe, B. D., Coster, R. V., & Roeyers, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274310 · Cited by 7
Lopresti, A. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00015-9 · Cited by 7
Metadata
- Authors
- Anglin, R. E., Garside, S. L., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I.
- Affiliations
- McMaster University (CA)
- Corresponding author
- Anglin, Rebecca E.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2012-04-15
- Volume
- 73
- Issue
- 04
- Pages
- 506-512
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2045758444
- Cited by
- 150
- References
- 0
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 14 · 2016: 6 · 2015: 12 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial disease, psychiatric symptoms, MELAS, mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes, borderline personality disorder, treatment-resistant depression, mood disorders, psychosis, anxiety, cognitive impairment, Kearns-Sayre syndrome, mitochondrial DNA deletions, underdiagnosis
- MeSH terms
- Mental Disorders, Bipolar Disorder, Brain, Depressive Disorder, Female, Humans, Magnetic Resonance Imaging, Middle Aged, MELAS Syndrome, Mitochondrial Diseases, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.